Vireo Growth logo

Vireo Growth(OTC) VREOF

Market Cap$508.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-93%
5 Year-78%
1 Year-45%
1 Month-9%
$9.85
+1.97%
+0.19Today
Vireo Growth last closing stock price
MetricPriceDate
Last closeUSD 9.852026-10-01
Vireo Growth stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-14.2%USD 11.482026-09-24
1 month-8.8%USD 10.802026-09-01
3 month-1.01%USD 9.952026-07-02
Year to date-46.43%USD 18.392025-12-31
1 year-44.99%USD 17.912025-10-01
3 year+89.24%USD 5.212023-10-02
5 year-78.02%USD 44.812021-10-01
Since inception-92.86%USD 138.012019-03-25

Vireo Growth Financials at a Glance

Market Cap

$508.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$511.67M

Net Income (TTM)

-$67.07M

EPS (TTM)

-$1.98

P/E Ratio

-4.98

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Price

$9.85

Volume

4,436

Open

$9.91

Previous Close

$9.85

Daily Range

$9.82 - $10.11

52-Week Range

$8.91 - $22.50

Estimated Earnings Date

Nov 11, 2026

VREOF News

3 pot stocks to buy in april

3 Things You Need to Know If You Buy Vireo Growth Today

James HalleyFeb 5, 2026
A person looking at a cannabis plant outdoors.

Do This Cannabis Company's New Name and Focus Make It a Better Buy?

David Jagielski, CPAJun 16, 2021
BruceLinton Thumb

Exclusive Interview: The Motley Fool Sits Down With Bruce Linton

Corinne Cardina JurneyOct 20, 2020
cannabis green light

Is This the Next Big Cannabis IPO?

David Jagielski, CPAMar 23, 2020
Close up of 100 dollar bill with marijuana leaf atop it

Ex-Canopy Growth CEO's Company Raising Up to $10 Million in New Financing

Eric VolkmanMar 10, 2020
cannabis greenhouse

Will This Be the Next Big Trend for the Cannabis Industry?

David Jagielski, CPAFeb 3, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vireo Growth

Vireo Growth Inc. is a cannabis company engaged in the cultivation, manufacturing, processing, and distribution of medical and adult-use cannabis products across several states in the U.S. The company operates a network of retail dispensaries and distributors, positioning itself as a key player in the expanding cannabis market.

Products and Services
  • Medical and adult-use cannabis products
  • Retail dispensaries in multiple states
  • Distribution through a network of partners
Growth Outlook
  • Revenue increased to $209.3 million in Q2 2026
  • Gross profit margin improved to 45.5% in Q2 2026
  • Expansion into new markets expected to drive future growth
Financial Highlights
  • Net income of -$10 million in Q2 2026
  • Operating income margin of -3.0% in Q2 2026
  • Cash and cash equivalents of $103.1 million as of June 30, 2026
Vireo Growth Inc. has demonstrated significant revenue growth, with Q2 2026 revenue reaching $209.3 million, a notable increase from previous quarters. The gross profit margin has also shown improvement, indicating better cost management and operational efficiency. Despite a net loss of $10 million in the latest quarter, the company maintains a strong cash position with over $103 million in cash and cash equivalents, providing a buffer for ongoing operations and potential expansion initiatives. The cannabis industry continues to evolve, and Vireo Growth Inc. is well-positioned to capitalize on emerging opportunities. The company's strategic focus on expanding its market presence and enhancing product offerings may contribute to long-term growth and profitability. Investors may find Vireo Growth Inc. an intriguing option within the cannabis sector, given its operational scale and market potential.
AI Generated • Sep 28, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

612

CEO

John Mazarakis, MBA

Website

www.vireogrowth.com

Headquarters

Minneapolis, MN 55402, US

VREOF Financials

Key Financial Metrics (TTM)

Gross Margin

48.64%

Operating Margin

1.35%

Net Income Margin

-13.11%

Return on Equity

-20.79%

Return on Capital

1.66%

Return on Assets

-5.27%

Earnings Yield

-20.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$508.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

51.59M

Volume

4.44K

Avg. Volume

40.97K

Financials (TTM)

Gross Profit

$248.87M

Operating Income

$6.91M

EBITDA

$47.87M

Operating Cash Flow

$26.16M

Capital Expenditure

-$143.68M

Free Cash Flow

-$117.52M

Cash & ST Invst.

$104.10M

Total Debt

$485.22M

Vireo Growth Performance Analysis

Vireo Growth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 74,625,86737.1%
20232023-12-31USD 88,133,16318.1%
20242024-12-31USD 99,384,22112.8%
20252025-12-31USD 268,769,268170.4%
Vireo Growth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3090.7%
Q42025-12-3114.0%
Q12026-03-311.6%
Q22026-06-3097.1%
Vireo Growth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -9.9421.8%
20232023-12-31USD -5.67-43.0%
20242024-12-31USD -4.66-17.8%
20252025-12-31USD -2.78-40.3%
Vireo Growth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-308.7%
Q42025-12-3128.1%
Q12026-03-315.2%
Q22026-06-3099.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$209.30M

+335.5%

Gross Profit

$95.30M

+366.7%

Gross Margin

45.53%

N/A

Market Cap

$508.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$830.29K

N/A

Employees

612

N/A

Net Income

-$100.00K

+99.3%

EBITDA

$19.00M

+4129.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$104.10M

+4.0%

Total Debt

$485.22M

+192.1%

Accounts Receivable

$87.00M

+145.9%

Inventory

$149.40M

+137.0%

Long Term Debt

$428.98M

+217.1%

Short Term Debt

$56.30M

+82.6%

Return on Assets

-5.27%

N/A

Return on Invested Capital

0.78%

N/A

Free Cash Flow

-$105.80M

-1100.3%

Operating Cash Flow

$2.40M

+149.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INNPFINNOCAN PHARMA Corp
$1.40-13.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$13.29+4.98%
HYGiShares Trust - iShares iBoxx $ High Yieldorate Bond ETF
$76.90+0.04%
NKENike
$35.15-0.71%
INTCIntel
$120.00-0.19%

Questions About VREOF

What is the current price of Vireo Growth?

Vireo Growth is trading at $9.85 per share.

What is the 52-week range for Vireo Growth?

Over the past 52 weeks, Vireo Growth has traded between $8.91 and $22.50.

How much debt does Vireo Growth have?

As of the most recent reporting period, Vireo Growth reported total debt of $485.80M.

How much cash does Vireo Growth have on hand?

Vireo Growth reported $122.70M in cash and cash equivalents in its most recent financial results.

What is Vireo Growth’s dividend yield?

Vireo Growth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services